Brief: Calian Wins Contract To Support Clinical Trial For Zyus Life Sciences’ Lead Drug Product Candidate
20/02/2024 22:56
Feb 20 (Reuters) - Calian Group Ltd CGY.TO :
* CALIAN WINS CONTRACT TO SUPPORT CLINICAL TRIAL FOR ZYUS
LIFE
SCIENCES’ LEAD DRUG PRODUCT CANDIDATE
* CALIAN GROUP LTD: CONTRACT TO SUPPORT PHASE 2 CLINICAL
TRIAL OF
ZYUS LIFE SCIENCE'S TRICHOMYLIN SOFTGEL CAPSULES
Source text for Eikon: ID:nGNXbY9xsg
Further company coverage: CGY.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan